Summary Analyses of prognostic factors have allowed the design of staging systems in different haematological disorders. In a series of 220 patients with multiple myeloma, univariate analysis showed that nine parameters had a significant adverse effect on survival; poor performance status (Karnowsky scaling system < 70%), infections before diagnosis, renal impairment (assessed either by creatinine clearance > 2 mg dl 1 or urea > 40 mg dl 1), serum calcium ( > O0 mg dl 1), severe anaemia ( < 8.5 g dl 1), the presence of Bence-Jones proteinuria, failure to achieve complete remission, more than 40% plasma cells in bone marrow and a low paraprotein index (monoclonal component/% plasma cells: P < 0.09). In addition, this index correlated significantly with all the other prognostic factors except performance status. The best combination of disease characteristics selected by means of the Cox regression proportional hazards method were performance status and creatinine levels. Additionally, by factor analysis of principal components we obtained a regression equation that included creatinine levels, haemoglobin, performance status and paraprotein index. Using this it was possible to separate the series of patients into three risk categories: A (65 patients), B (69 patients) and C (65 patients 
Patients with multiple myeloma (MM) display a very heterogeneous clinical and biological course, their survival ranging from a few months to more than 5 years (Durie & Salmon, 1982; Hansen & Galton, 1985; Kyle, 1984) . Analysis of prognostic factors has permitted the design of staging systems that will facilitate the prognostic categorisation of patients and the evaluation of different treatment protocols. However, even within a single clinical stage there continue to be patients with considerable clinical variability, which necessitates the search for new parameters that will allow a better individual control of each patient. Moreover, some of the classification models proposed (Durie & Salmon, 1975; Merlini et al., 1980) have shown poor discriminatory power when assayed in other series of patients (Bettini et al., 1983; Blad& & Rozman, 1984; Durie et al., 1980; Gavagnaro et al., 1980; Hansen et al., 1973; Hernandez & San Miguel, 1984; Pennec et al., 1983; Vercelli et al., 1981) .
Most of these studies have been performed on the basis of univariate analysis (Adachi et al., 1982; Bartl et al., 1982; Bergsagel et al., 1979; Brian et al., 1980; Buckman et al., 1982; Carbone et al., 1967; Costanzi et al., 1985; Harley et al., 1979; Pesce et al., 1983; Vercelli et al., 1980 Vercelli et al., , 1981 , there being few works that use multivariate methods (Blade & Rozman, 1984; Cohen et al., 1979; Durie & Salmon, 1975; Durie et al., 1980; Hernandez & San Miguel, 1984; Kyle, 1983 Kyle, , 1984 Matzner et al., 1978; Merlini et al., 1980) and to the best of our knowledge none has employed factor analysis by the principal components method.
The aim of the present study was to identify significant prognostic factors in a series of 220 MM patients. Additionally, an attempt was made to develop a staging system from the results of such analysis and compare this with other well-established systems (Carbone et al., 1967; Durie & Salmon, 1975 ; Medical Research Council's Working Party on Leukaemia in Adults, 1980; Merlini et al., 1980 (Dixon, 1985; Cox & Dakes, 1985) . The cut-off of each parameter was selected by starting at its median value and then cutting at different levels above and below, until significance was eventually obtained.
Subsequently, a multivariate analysis was performed to examine the simultaneous effect of the different variables on survival by the stepwise proportional hazards regression model for censored survival data (BMDP 2L) (Cox, 1972) . Variables considered for possible inclusion in the Cox regression analyses were those for which there was some indication of a significant association with survival in univariate analysis (P < 0.10) or for which prior studies had suggested a possible association. 
Results
The univariate analysis showed that nine parameters had a significant adverse effect on survival (Table I) : poor performance status (Karnofsky scaling system < 70%), infections before diagnosis, renal impairment (assessed either by creatinine clearance > 2mgdl-1 or urea > 40mgdl-1), serum calcium ( >10mgdl-1), severe anaemia (<8.5gdl-1), presence of Bence-Jones proteinuria, failure to achieve complete remission, more than 40% plasma cells in bone marrow and a low paraprotein index (<0.09). The median value for this latter parameter in our series was 0.1 and in addition, the paraprotein index correlated significantly with all the other prognostic factors except performance status (Table II) .
The best combination of patients and disease characteristics selected by means of the Cox regression proportional hazards method both in the binary and continuous models were the performance status and the creatinine level (Table III) . Since performance status could be considered as a subjective measurement, a new regression analysis excluding this variable was performed, the characteristics selected being creatinine level (P < 0.0004) and haemoglobin (P < 0.02).
The principal component analysis showed that the four variables that had the highest correlation with the first component were Figure 4 Staging system of Carbone et al. (1967) . 0 risk factor, 30 months; risk factor, ---28 months; 2 risk factor, 15 months; 3 risk factor, 12 months. 0 and I versus 2 and 3, P<0.000l. Carbone et al., 1967; Costanzi et al., 1985; Durie & Salmon, 1975; Durie et al., 1980; Hansen & Galton, 1985; Hernandez & San Miguel, 1984; Matzner et al., 1978) ; this has led to the description of numerous staging systems (Alexanian et al., 1975; Costa et al., 1973; Durie & Salmon, 1975; Medical Research Council's Working Party on Leukaemia in Adults, 1980; Merlini et al., 1980; Southeastern Cancer Study Group, 1975) . However, few critical papers have been devoted to such classifications (Bettini et al., 1983; Cavagnaro et al., 1980; Gassmann et al., 1985; Pennec et al., 1983; Vercelli et al., 1981) and in fact the model of Durie & Salmon (1975) continues to be the most popular one despite several studies having thrown doubt on its real prognostic value (Blade & Rozman, 1984; Durie et al., 1980; Gavagnaro et al., 1980; Hern'andez & San Miguel, 1984; Merlini et al., 1980; Yercelli et al., 1981) . In the present work, apart from analysing four of the most popular staging systems, a new model is proposed that was obtained by statistical analysis of principal components; this model also includes a new parameter that relates the monoclonal component with the percentage of plasma cells (paraprotein index).
Univariate analysis of our patients pointed to the existence of nine prognostic factors: poor performance status, infections before diagnosis, renal insufficiency, hypercalcaemia, severe anaemia, Bence-Jones proteinuria, failure to achieve complete remission, high plasma cell infiltration and a low paraprotein index. Recently, Hansen & Galton (1985) have reviewed the prognostic factors with significance for survival in myelomatosis; of them the only important one that does not appear in our study is serum albumin concentration (Alexanian et al., 1975; Bataille et al., 1979) . In our series, although hypoalbuminaemia (<3 g dl -1) was associated with a shorter survival the differences were not statistically significant. On the other hand, infections before diagnosis, a feature which has not received much attention, was associated with an adverse prognosis in our patients.
Recently, some new parameters, such as thymidine kinase (Simonsson et al., 1985) , T-cell subsets (San Miguel et al., 1985) , plasma cell morphology (Greipp et al., 1985) , plasma cell antigens (Ruiz Arguelles et al., 1984; San Miguel et al., 1987) , plasma cell labelling index and beta-2-microglobulin (Bataille et al., 1984; Brenning et al., 1986; Cuzick et al., 1985; Van Dobbenburgh et al., 1985) have emerged as possible prognostic factors in multiple myeloma. Of all these, the latter has been the most extensively analysed, being assessed in most studies as an important prognostic variable (Bataille et al., 1984; Brenning et al., 1986; Cuzick et al., 1985) . Moreover, in a recent series Cuzick et al. (1985) have shown that beta-2-microglobulin was the most powerful independent prognostic factor. We have studied this parameter in 58 MM patients and 21 patients with essential monoclonal gammopathy (data not shown), and have found that the levels beta-2-microglobulin correlated with both the amount of paraprotein and advanced clinical stages and, in addition, could be a useful parameter for the differential diagnosis of monoclonal gammopathies (Ortega et al., 1986) . These data show that any analysis of prognostic factors in multiple myeloma should in future include these new variables in order to perfect the prognostic models that will permit a better stratification of the patients and the evaluation of treatment protocols.
In MM patients the M-component synthesized is proportional to the total plasma cell mass (Salmon & Smith, 1970) , but neither the monoclonal component nor the percentage of plasma cells, in spite of being key criteria for the diagnosis of MM, have a definite prognostic value (Hansen & Galton, 1985) . Accordingly, we thought it of interest to search for a variable of easy clinical application that would relate the production of Igs and plasma cells: the paraprotein index (PI). In our series the patients with a low PI had unfavourable clinico-biological features and shorter survivals. The low capacity of Ig synthesis of these cases could reflect the existence of a blockage in Ig secretion (Qian et al., 1984) , and it would be important to rule out that these plasma cells might be at an earlier stage of maturation that could be associated with a different response to chemotherapy (San Miguel et al., 1987) .
Although multivariate analyses are much scarcer (Blade & Rozman, 1984; Cohen et al., 1979; Durie & Salmon, 1975; Durie et al., 1980; Hernandez & San Miguel, 1984; Kyle, 1983 Kyle, , 1984 Matzner et al., 1978; Merlini et al., 1980) , they have the advantage of considering the simultaneous effect of the different variables on survival, which facilitates the grouping of patients according to the real major prognostic features. The method most commonly employed is the stepwise proportional hazards regression model of Cox (Cox, 1972; Cox & Dakes, 1985) . Using this method in our series the best combination of independent prognostic variables in predicting survival was renal function and performance status. These two factors, together with haemoglobin and to a lesser extent calcium, have been those identified with the highest frequency as a significant risk factor in other multivariate analyses (Hansen & Galton, 1985; Harley et al., 1979; Matzner et al., 1978; Merlini et al., 1980) . Using principal component analysis, a statistical approach that has only been used occasionally, we found that the combination of clinical performance status, serum creatinine, haemoglobin and paraprotein index allowed us to discriminate three groups of patients with different survivals. This staging system provided very similar results to those of the MRC (1980), with an even lower level of wrongly classified patients. This is understandable since both models contain similar criteria, with the exception of the paraprotein index which hitherto has not been explored. In contrast, and as evidenced by other studies (Bettini et al., 1983; Blade & Rozman, 1984; Durie et al., 1980; Gavagnaro et al., 1980; Gassmann et al., 1985; Hansen & Galton, 1985; Hernandez & San Miguel, 1984; Merlini et al., 1980; Vercelli et al., 1981) , the staging systems proposed by Merlini et al. (1980) , Durie & Salmon (1975) and Carbone et al. (1967) did not discriminate prognostic subgroups.
Our study thus indicates that principal component analysis may be a useful complementary tool for classifying patients according to prognostic factors and the paraprotein index could be a simple parameter of great use in clinical practice.
